HCP Live December 15, 2023
Kevin Kunzmann

Califf joins HCPLive to share perspective on AI, gene and cell therapy development, COVID-19, food and substance regulation, maternal and infant health, weight loss intervention, and more.

Since 2017, HCPLive has published hundreds of end-of-year feature articles and multimedia reviews as part of the annual This Year in Medicine series. Over those 7 years, the most returned-to subjects by our staff and clinician experts alike have pertained to key decisions from the US Food and Drug Administration (FDA): more often than not, when a specialist is asked, ‘What was the biggest news in your field this year?’ their mind goes to practice-changing drug approval or regulatory decisions. Just read our advisory board’s top story picks this year to see for...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, FDA, Govt Agencies, Trends
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices

Share This Article